✳flâneur — a map of the web's best reading

The Promise of DAOs in Drug Discovery

biopharmatrend.com · 1,178 words · saved by 1 readers

Disclaimer: All opinions expressed by Contributors are their own and do not represent those of their employers, or BiopharmaTrend.com. Contributors are fully responsible for assuring they own any required copyright for any content they submit to BiopharmaTrend.com. This website and its owners shall not be liable for neither information and content submitted for publication by Contributors, nor its accuracy. In August, Pfizer announced it requested to join VitaDAO with a half-a-million bid. VitaDAO is a new type of decentralized autonomous organization (DAOs) built on blockchain technology. DAOs are new smart contract-based entities that enable capital, talent, and crowd intelligence exchange between several organizations. DAOs operate by rules and financial transactions encoded on a transparent blockchain architecture, controlled by the stakeholders and not influenced by a central governing body, like in a usual company. Essentially, DAOs are member-owned. Pfizer’s bid

In August, Pfizer announced it requested to join VitaDAO with a half-a-million bid. VitaDAO is a new type of decentralized autonomous organization (DAOs) built on blockchain technology. DAOs are new smart contract-based entities that enable capital, talent, and crowd intelligence exchange between several organizations. DAOs operate by rules and financial transactions encoded on a transparent blockchain architecture, controlled by the stakeholders and not influenced by a central governing body, like in a usual company. Essentially, DAOs are member-owned. Pfizer's bid to join VitaDAO is likely t

Explore this link on the map →

related reading